[Health related quality of life and lipodystrophy syndrome among HIV-infected patients].
OBJECTIVE
The aim of this work is to show to what extent a psychosocial evaluation can lead bring to comprehension of the subjectivity of Quality of Life (QoL) among HIV-infected patients. Evaluation of QoL makes it possible to understand the link between the therapeutic effectiveness and the subjective evaluation of the treatment, but also to estimate more precisely how people live and take their treatment in the context of HIV infection.


METHODS
This work confronts the variation of QoL with the variation of several social and psychosocial parameters identified as of the components of the system, which is the subjective evaluation, and more precisely to a specific side effect of Highly Active AntiRetroviral Therapies (HAART): lipodystrophy syndrome that consists in body fat redistribution. This side effect could consist in an accumulation of body fat, or a loss of body fat or a combination of both symptoms. The analysis was made on the data from APROCO-COPILOTE cohort composed of HIV-infected patients initiating HAART.


RESULTS
Among a sample of 706 patients follow-up for three years and with available QoL data, we identified the variations of QoL according to the variation of this specific side effect and according to gender. Results show that lipodystrophy syndrome has a determinant impact on QoL different among male and female patients. Adjusted on clinical and socio-demographic characteristics, impaired women's QoL is associated with accumulation of body fat and impaired men's QoL is associated with loss of body fat.


CONCLUSIONS
These results underline the role of body image on subjective evaluation of QoL. The analysis of empirical data made it possible to highlight the social implication of the evaluation of QoL from the role of the social support, patient-provider relationship and the social context.
Préau
M
M
Equipe Psychologie Sociale de la Santé, Laboratoire de Psychologie Sociale, Université de Provence, Aix-en-Provence.
Bouhnik
A-D
AD
Spire
B
B
Leport
C
C
Saves
M
M
Picard
O
O
Reynes
J
J
Salmon
D
D
Dellamonica
P
P
Raffi
F
F
Morin
M
M
Aproco-Copilote
Etlegrouped'étude
E
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D001828:Body Image; D015331:Cohort Studies; D005260:Female; D005602:France; D015658:HIV Infections / Q000188:drug therapy / Q000523:psychology*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced / Q000523:psychology*; D006306:Health Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011788:Quality of Life / Q000523:psychology*; D012737:Sex Factors; D012917:Social Adjustment